State Of Wyoming Reata Pharmaceuticals Inc Transaction History

State Of Wyoming

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$20.71 - $36.5 $82 - $146	4 Added 26.67%	19 $1,000
Q1 2022 May 13, 2022	BUY	$24.12 - $39.6 $72 - $118	3 Added 25.0%	15 $0
Q4 2021 Feb 11, 2022	SELL	$25.61 - $110.96 $25 - $110	-1 Reduced 7.69%	12 $0
Q3 2021 Feb 11, 2022	SELL	$100.0 - $143.02 $600 - $858	-6 Reduced 31.58%	13 $1,000
Q2 2021 Feb 11, 2022	BUY	$78.27 - $151.29 $782 - $1,512	10 Added 111.11%	19 $3,000
Q1 2021 Feb 08, 2022	BUY	$94.25 - $132.81 $848 - $1,195	9 New	9 $1,000

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.